These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 32026769)

  • 1. Lipid-Based Nanosystem As Intelligent Carriers for Versatile Drug Delivery Applications.
    Harshita ; Barkat MA; Das SS; Pottoo FH; Beg S; Rahman Z
    Curr Pharm Des; 2020; 26(11):1167-1180. PubMed ID: 32026769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
    Okur NÜ; Siafaka PI; Gökçe EH
    Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
    Talegaonkar S; Bhattacharyya A
    AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances.
    Shreya AB; Raut SY; Managuli RS; Udupa N; Mutalik S
    AAPS PharmSciTech; 2018 Dec; 20(1):15. PubMed ID: 30564942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs.
    Cai Z; Wang Y; Zhu LJ; Liu ZQ
    Curr Drug Metab; 2010 Feb; 11(2):197-207. PubMed ID: 20384585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Armamentarium of nanoscaled lipid drug delivery systems customized for oral administration: In silico docking patronage, absorption phenomenon, preclinical status, clinical status and future prospects.
    Baldi A; Chaudhary M; Sethi S; Abhiav ; Chandra R; Madan J
    Colloids Surf B Biointerfaces; 2018 Oct; 170():637-647. PubMed ID: 29986259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Enhancing Oral Drug Absorption: Overcoming Physiological and Pharmaceutical Barriers for Improved Bioavailability".
    Maurya R; Vikal A; Patel P; Narang RK; Kurmi BD
    AAPS PharmSciTech; 2024 Oct; 25(7):228. PubMed ID: 39354282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.
    Cherniakov I; Domb AJ; Hoffman A
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1121-33. PubMed ID: 25556987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentials and challenges in self-nanoemulsifying drug delivery systems.
    Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
    Expert Opin Drug Deliv; 2012 Oct; 9(10):1305-17. PubMed ID: 22954323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured Lipid Carriers- A Versatile Carrier for Oral Delivery of Lipophilic Drugs.
    Patel P; Patel M
    Recent Pat Nanotechnol; 2021; 15(2):154-164. PubMed ID: 32912129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
    Silva AC; Santos D; Ferreira D; Lopes CM
    Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of solid lipid nanoparticles-a review.
    Parhi R; Suresh P
    Curr Drug Discov Technol; 2012 Mar; 9(1):2-16. PubMed ID: 22235925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based nanocarriers for enhanced delivery of plant-derived bioactive molecules: a comprehensive review.
    Kothapalli P; Vasanthan M
    Ther Deliv; 2024 Feb; 15(2):135-155. PubMed ID: 38214118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanonization techniques to overcome poor water-solubility with drugs.
    Da Silva FLO; Marques MBF; Kato KC; Carneiro G
    Expert Opin Drug Discov; 2020 Jul; 15(7):853-864. PubMed ID: 32290727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocarriers protecting toward an intestinal pre-uptake metabolism.
    Suchaoin W; Bernkop-Schnürch A
    Nanomedicine (Lond); 2017 Feb; 12(3):255-269. PubMed ID: 28093952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins.
    Hsu CY; Wang PW; Alalaiwe A; Lin ZC; Fang JY
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCS class IV drugs: Highly notorious candidates for formulation development.
    Ghadi R; Dand N
    J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.